Phagocytosis checkpoints like CD47, CD24, MHC-I, and PD-L1 play a critical role in cancer immunotherapy by acting as escape signals from immunogenic cells, thereby weakening the immune activity against tumors (30, 31). This evidence concerns the gene CD47 and cancer.